No results found.
Shannon Palermo, VMD, University of Pennsylvania
Sign in to Print/View PDF
This is a filled error message
To access full articles on www.cliniciansbrief.com, please sign in below.
Create an account for free
Want free access to the #1 publication for diagnostic and treatment information? Create a free account to read full articles and access web-exclusive content on cliniciansbrief.com.
Passwords do not match
Where are you from?
AG|Antigua and Barbuda
BA|Bosnia and Herzegovina
IO|British Indian Ocean Territory
CF|Central African Republic
CC|Cocos (Keeling) Islands
CD|Congo, the Democratic Republic of the
FK|Falkland Islands (Malvinas)
TF|French Southern Territories
HM|Heard Island and McDonald Islands
VA|Holy See (Vatican City State)
KR|Korea, Republic of
LY|Libyan Arab Jamahiriya
MK|Macedonia, the former Yugoslav Republic
FM|Micronesia, Federated States of
MD|Moldova, Republic of
MP|Northern Mariana Islands
PG|Papua New Guinea
KN|Saint Kitts and Nevis
VC|Saint Vincent and the Grenadines
ST|Sao Tome and Principe
GS|South Georgia and the South Sandwich Islands
PM|Saint Pierre and Miquelon
SJ|Svalbard and Jan Mayen
SY|Syrian Arab Republic
TW|Taiwan, Province of China
TZ|Tanzania, United Republic of
TT|Trinidad and Tobago
TC|Turks and Caicos Islands
AE|United Arab Emirates
UM|United States Minor Outlying Islands
VG|Virgin Islands, British
VI|Virgin Islands, U.S.
WF|Wallis and Futuna
DC|District of Columbia
Micronesia (Federated States Of)
US Minor Outlying Islands
Armed Forces Africa
Armed Forces Americas Aa (except Canada)
Armed Forces Canada
Armed Forces Europe Ae
Armed Forces Middle East Ae
Armed Forces Pacific Ap
PE|Prince Edward Island
Tell us about yourself
Choose the category that describes your business/professional activity
What best describes your position? (question 1 of 2)
Veterinarian Role: (question 2 of 2)
Non-Veterinarian Role: (question 2 of 2)
Yes, I would like to receive updates about products & services, promotions, special offers, news & events from Brief Media.
Already have an account? Sign in here.
Acceptance to the GDPR regulations is required.
Sponsored by Spectrum
Although the best form of treatment for allergies is avoidance of the offending allergens, avoidance is not always possible. Suppression or comfort therapies (eg, steroids, antihistamines, cyclosporine, antipruritics) may provide some relief to patients suffering from allergies; however, these therapies are costly, commonly have side effects, and may have side effects with long-term use that are yet unknown. Hyposensitization, a safe and effective alternative, is considered the gold standard for atopy treatment and is the only available treatment that addresses the root cause of clinical signs.
The first step in successful treatment of allergic disease is a proper diagnosis. Without a proper allergy diagnosis, many pets are given multiple medications in an attempt to relieve clinical signs. Only when proper allergen specific testing is initiated can there be an appropriate diagnosis, which is the first step toward successful treatment. Allergen-specific IgE serology and intradermal tests have become widely used to diagnose allergies and are both sensitive and specific.1
The ultimate goal of hyposensitization therapy is to restore or increase tolerance to the offending allergen by reducing IgE production. In other words, hyposensitization therapy aims to reprogram the immune system to prevent overreaction to the specific allergens that cause problems for the pet. Desensitization occurs by administering increasing doses of the offending allergen, which over time decreases the immune system IgE response. This therapy also results in a decrease in mast cell and basophil production, which both contribute to the secondary inflammation associated with allergy. There are two forms of hyposensitization therapy currently available: subcutaneous injections and sublingual drops.
Hyposensitization injections allow patients to develop immunity to specific allergens following a positive allergy test; this results in diminished or absent immune response. Injections provide successful treatment for approximately 65% of patients2 and are administered over a 9-month period, in increasing doses as well as increasing concentrations. This initial hyposensitization period is followed by monthly maintenance injections to maintain the pet’s increased tolerance to allergens. Injections may take several months to become effective, but they can be continued safely throughout the pet’s life. The first injection of each vial should be given in-house to ensure proper compliance.
Sublingual drops are the perfect solution for pets and owners that prefer a needle-free option. Additionally, they may be an effective option for dogs that have “failed injection immunotherapy due to lack of efficacy, adverse reactions, or compliance difficulties.”3 Unlike injectable therapy, daily administration is required; therefore, compliance may be a concern. Although drops may be easier for some pets and clients, they can be costlier than injections over the pet’s lifespan, and response time may be shorter with this form of therapy.2 Food and liquid must be withheld 10 minutes prior to and after administration of the drops for full efficacy.
References and Author Information
Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*
*2007-2017 PERQ and Essential Media Studies
It's Free & Simple
Delivered to Your Inbox
Join the Conversation
Follow us @CliniciansBrief
© 2018 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved.